Notice2021-11504
Meeting of the Advisory Committee on Infant Mortality
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
June 2, 2021
Issuing agencies
Health and Human Services DepartmentHealth Resources and Services Administration
Abstract
In accordance with the Federal Advisory Committee Act, this notice announces that the Advisory Committee on Infant Mortality (ACIM) has scheduled a public meeting. Information about ACIM and the agenda for this meeting can be found on the ACIM website at https:// www.hrsa.gov/advisory-committees/infant-mortality/index.html.
Full Text
<html>
<head>
<title>Federal Register, Volume 86 Issue 104 (Wednesday, June 2, 2021)</title>
</head>
<body><pre>
[Federal Register Volume 86, Number 104 (Wednesday, June 2, 2021)]
[Notices]
[Page 29588]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2021-11504]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Health Resources and Services Administration
Meeting of the Advisory Committee on Infant Mortality
AGENCY: Health Resources and Services Administration (HRSA), Department
of Health and Human Services (HHS).
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: In accordance with the Federal Advisory Committee Act, this
notice announces that the Advisory Committee on Infant Mortality (ACIM)
has scheduled a public meeting. Information about ACIM and the agenda
for this meeting can be found on the ACIM website at <a href="https://www.hrsa.gov/advisory-committees/infant-mortality/index.html">https://www.hrsa.gov/advisory-committees/infant-mortality/index.html</a>.
DATES: June 22, 2021, 12:00 p.m.-4:00 p.m. Eastern Time (ET) and June
23, 2021, 12:00 p.m.-4:00 p.m. ET.
ADDRESSES: This meeting will be held via webinar. The webinar link and
log-in information will be available at ACIM's website before the
meeting: <a href="https://www.hrsa.gov/advisory-committees/infant-mortality/index.html">https://www.hrsa.gov/advisory-committees/infant-mortality/index.html</a>.
FOR FURTHER INFORMATION CONTACT: Vanessa Lee, MPH, Acting Designated
Federal Official, Maternal and Child Health Bureau, HRSA, 5600 Fishers
Lane, Rockville, Maryland 20857; 301-443-0543; or <a href="/cdn-cgi/l/email-protection#d88b999b919598b0aaabb9f6bfb7ae"><span class="__cf_email__" data-cfemail="0a594b4943474a6278796b246d657c">[email protected]</span></a>.
SUPPLEMENTARY INFORMATION: The ACIM is authorized by section 222 of the
Public Health Service Act (42 U.S.C. 217a), as amended. The Committee
is governed by provisions of Public Law 92-463, as amended, (5 U.S.C.
App. 2), which sets forth standards for the formation and use of
Advisory Committees.
The ACIM advises the Secretary of HHS on department activities and
programs directed at reducing infant mortality and improving the health
status of pregnant women and infants. The ACIM represents a public-
private partnership at the highest level to provide guidance and focus
attention on the policies and resources required to address the
reduction of infant mortality and the improvement of the health status
of pregnant women and infants. With a focus on life course, the ACIM
addresses disparities in maternal health to improve maternal health
outcomes, including preventing and reducing maternal mortality and
severe maternal morbidity. The ACIM provides advice on how best to
coordinate myriad federal, state, local, and private programs and
efforts that are designed to deal with the health and social problems
impacting infant mortality and maternal health, including
implementation of the Healthy Start program and maternal and infant
health objectives from the National Health Promotion and Disease
Prevention Objectives (i.e., Healthy People 2030).
The agenda for the June 22-23, 2021, meeting is being finalized and
may include the following topics: Discussion of recommendations by ACIM
to the Secretary; updates from HRSA's Maternal and Child Health Bureau,
and other federal agencies; the Centers for Disease Control and
Prevention's Pregnancy Risk Assessment Monitoring System survey; and
patient-physician racial concordance in health care. Agenda items are
subject to change as priorities dictate. Refer to the ACIM website for
any updated information concerning the meeting.
Members of the public will have the opportunity to provide written
or oral comments. Requests to submit a written statement or make oral
comments to the ACIM should be sent to Vanessa Lee, using the email
address above at least 3 business days prior to the meeting. Public
participants may submit written statements in advance of the scheduled
meeting by emailing <a href="/cdn-cgi/l/email-protection#ffacbebcb6b2bf978d8c9ed1989089"><span class="__cf_email__" data-cfemail="fba8bab8b2b6bb9389889ad59c948d">[email protected]</span></a>. Oral comments will be honored in
the order they are requested and may be limited as time allows.
Individuals who plan to attend and need special assistance or
another reasonable accommodation should notify Vanessa Lee at the
contact information listed above at least 10 business days prior to the
meeting.
Maria G. Button,
Director, Executive Secretariat.
[FR Doc. 2021-11504 Filed 6-1-21; 8:45 am]
BILLING CODE 4165-15-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on June 2, 2021.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.